Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 73, 41-50
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Histone H3 mutations—a special role for H3.3 in tumorigenesis?Chromosoma, 2015
- Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimicsThe Journal of Pathology: Clinical Research, 2015
- A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasActa Neuropathologica, 2014
- Histological and clinical characteristics of malignant giant cell tumor of boneVirchows Archiv, 2012
- Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western IndiaAnnals of Diagnostic Pathology, 2008
- Molecular identification of COL6A3‐CSF1 fusion transcripts in tenosynovial giant cell tumorsGenes, Chromosomes and Cancer, 2007
- Osteoblast lineage properties in giant cell tumors of boneJournal of Orthopaedic Science, 2005
- Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of boneBone, 2004
- Malignancy in giant cell tumor of boneCancer, 2003
- Human osteoclastoma-derived stromal cells: Correlation of the ability to form mineralized nodules in vitro with formation of bone in vivoJournal of Bone and Mineral Research, 1996